Most people have never heard of DEHP. But it’s almost certainly in your home right now — in your shower curtain, in children’s toys, in medical devices, in raincoats and plastic tubing and dozens of other products most of us interact with daily without a second thought.
New research presented at ENDO 2026 suggests that this near-universal chemical may be doing something to the developing brain that lasts a lifetime. And the most alarming part is that the exposure responsible for those lasting changes happens before birth.
What DEHP Is And Where It’s Found
Di-(2-ethylhexyl) phthalate — DEHP — is a plasticizer. Its job is to make rigid PVC plastic flexible and durable. Because of how effectively it does that job, it became one of the most widely used chemical additives in modern manufacturing, incorporated into an enormous range of products including medical devices, flooring, food packaging, shower curtains, raincoats, and children’s toys.
The problem is that DEHP doesn’t stay put. It leaches from plastic over time and enters the body through ingestion, inhalation, and skin contact. It has been detected in human blood, urine, and breast milk worldwide. Previous research had already linked DEHP to disruptions in reproductive development, particularly in males — effects on testosterone levels and sperm function are among the most well-documented consequences of early exposure.
This new study adds something different to that picture: lasting anxiety.
What The Researchers Did
Scientists at the University of Buenos Aires School of Medicine, led by Professor Osvaldo Juan Ponzo, conducted a controlled experiment in rats to investigate whether early DEHP exposure could influence anxiety-related behavior in adulthood — and whether the brain chemical GABA or testosterone might be involved in those effects.
Pregnant female rats received daily oral doses of DEHP beginning on the first day of pregnancy and continuing until their pups were weaned. Once the male offspring reached adulthood at 70 days of age — well past any DEHP exposure — the researchers assessed anxiety using an elevated plus maze, a standard rodent behavior test.
The maze exploits a fundamental tendency in rodents: they naturally avoid open, exposed areas and prefer enclosed spaces. Researchers measured how often the animals entered the open arms of the maze, how long they stayed, and how frequently they froze in place — a classic fear response. The more time spent in enclosed areas and the more freezing behavior observed, the greater the anxiety.
The Results Were Unambiguous
Male rats exposed to DEHP during early development showed clearly elevated anxiety compared to unexposed controls. They spent significantly less time exploring the open arms, stayed longer in the enclosed arms, and froze more frequently.
Critically, this was happening in adulthood — long after any DEHP was present in their bodies. The chemical had left the system, but its impact on brain development had not.
The researchers then tested whether GABA agonists or testosterone could reverse these behavioral effects. They could. DEHP-exposed rats given either treatment before the maze test behaved more like unexposed animals — exploring more freely, freezing less, spending more time in open areas.
This finding is significant because it points directly to the mechanism. DEHP appears to interfere during early development with the brain’s GABAergic system — the primary inhibitory neurotransmitter network that regulates anxiety, stress responses, and emotional regulation — and with testosterone-dependent developmental pathways. The disruption is programming something into the brain during a narrow developmental window that then persists into and throughout adulthood.
“This work demonstrates that contact with DEHP in the early stages of life could modify behavior with regard to anxiety, even in the absence of DEHP exposure in adulthood,” said Ponzo. “These neuroendocrine changes can be reversed by treating with GABA agonists or testosterone.”
Why This Matters Beyond The Lab
The study was conducted in rats, and translating animal findings directly to human outcomes requires caution and further research. What happens in a rodent’s developing nervous system does not always map cleanly onto human neurodevelopment.
But the concern is not hypothetical. DEHP has already been linked to heart disease deaths in a 2025 study estimating that DEHP exposure contributed to over 356,000 cardiovascular deaths globally in 2018. A separate 2025 study testing urine from toddlers found 96 different chemicals present, many of them endocrine disruptors like DEHP. Human exposure to this chemical is not rare or edge-case — it is effectively universal in industrialized countries.
The developing brain during pregnancy and the weeks immediately after birth represents one of the most sensitive windows in human biology. Disruptions during that period — from hormones, from stress, from environmental chemicals — can alter developmental trajectories in ways that don’t become visible until years or decades later.
If early DEHP exposure is doing to the human developing brain something like what this study found in rats, the implications for anxiety rates, mental health, and neurodevelopmental outcomes at a population level are worth taking seriously.
What Can Be Done
Complete elimination of DEHP exposure is effectively impossible given how widely it is used, but meaningful reduction is achievable. Avoiding plastic food containers labeled with recycling code 3, choosing DEHP-free alternatives for children’s products and medical equipment where possible, reducing plastic food contact particularly with fatty foods (since DEHP migrates more readily into fats), and advocating for stronger regulatory limits on phthalates in consumer products are practical steps that can lower exposure.
Regulatory pressure is already building. DEHP is restricted or banned in children’s products in the EU and in several other jurisdictions. The US has implemented some restrictions but enforcement and scope remain inconsistent.
The chemical that makes your shower curtain flexible has been quietly present in human bodies for decades. Research is only now beginning to reveal the full cost of that presence — and what it may have been doing to developing brains all along. 🧬
Source: The Endocrine Society / ENDO 2026 Annual Meeting, Chicago — June 17, 2026
Note: This study was presented as a conference abstract. Lead researcher: Dr. Osvaldo Juan Ponzo, University of Buenos Aires School of Medicine, Buenos Aires, Argentina.
